Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non‐small cell lung cancer
Cancer Medicine · 2023
DOI: 10.1002/cam4.5647 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Ryota Nakamura und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pulmonary Embolism. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lung cancer patients face a high risk of thromboembolism (TE), which is considered to be a poor prognostic factor. However, the impact of symptomatic cerebral infarction (CI) and pulmonary embolism (PE) on the prognosis of advanced non‐small cell lung cancer (NSCLC) patients is not fully understood.
Methods
We retrospectively identified 46 patients with advanced NSCLC who developed symptomatic CI or PE at five hospitals in Japan between January 2010 and December 2019. Prognosis and biomarker levels after incident CI and PE were investigated.
Results
Of the 46 patients, 36 developed symptomatic CI, and 10 developed symptomatic PE. The median follow‐up duration after incident CI and PE was 18.2 months. Although the proportion of Common Terminology Criteria for Adverse Events grade 4 tended to be higher in patients with PE than in those with CI (30% vs. 11%, p = 0.16), the overall survival (OS) after incident TE tended to be worse in patients with CI than in those with PE (median 2.3 months vs. 9.1 months, log‐rank test p = 0.17). Multivariate analysis showed that OS after CI was worse in patients with high D‐dimer (DD) levels than in those with low DD levels at the time of incident CI (median 1.3 months vs. 8.3 months, log‐rank p < 0.001).
Conclusions
This retrospective study demonstrated that the prognosis of patients tended to be poorer after CI than after PE. The DD levels at the time of incident CI might be a promising predictor of clinical outcomes in advanced NSCLC patients who develop CI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Department of Respiratory Medicine, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
- Department of Pulmonary Medicine, Japan Community Health care Organization Kyoto Kuramaguchi Medical Center, Kyoto, Japan.
- Department of Respiratory Medicine, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
- Department of Respiratory Medicine, Uji-Tokushukai Medical Center, Kyoto, Japan.
- Department of Pulmonary Medicine, Otsu City Hospital, Shiga, Japan.
ORCID-Profile: Ryota Nakamura, Tadaaki Yamada, Takayuki Takeda, Koichi Takayama
Zitieren
APA
Nakamura, R., Yamada, T., Tanaka, S., Sasada, A., Shiotsu, S., Tani, N., Takeda, T., Chihara, Y., Hirai, S., Takemura, Y., Yoshimura, A., Morimoto, K., Iwasaku, M., Tokuda, S., Kim, Y. H., & Takayama, K. (2023). Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non‐small cell lung cancer. Cancer Medicine. https://doi.org/10.1002/cam4.5647
Vancouver
Nakamura R, Yamada T, Tanaka S, Sasada A, Shiotsu S, Tani N, et al. Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non‐small cell lung cancer. Cancer Medicine. 2023. doi:10.1002/cam4.5647
BibTeX
@article{Nakamura2023,
author = {Nakamura, Ryota and Yamada, Tadaaki and Tanaka, Satomi and Sasada, Aosa and Shiotsu, Shinsuke and Tani, Nozomi and Takeda, Takayuki and Chihara, Yusuke and Hirai, Soichi and Takemura, Yoshizumi and Yoshimura, Akihiro and Morimoto, Kenji and Iwasaku, Masahiro and Tokuda, Shinsaku and Kim, Young Hak and Takayama, Koichi},
title = {Comparison of the prognosis of symptomatic cerebral infarction and pulmonary embolism in patients with advanced non‐small cell lung cancer},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.5647}
}
EUVIMED